SynthesisThe journal of headache and pain2022

The efficacy and safety of atogepant for the prophylactic treatment of migraine: evidence from randomized controlled trials.

Xinyu Tao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.